Multimodal Biomarkers for Diagnosis and Prognosis in CAA
NCT03969732
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Cerebral Amyloid Angiopathy
Intracranial Hemorrhages
Alzheimer Disease
Interventions
DRUG:
1. amyloid PET；2. T807 PET
Sponsor
National Taiwan University Hospital